NASDAQ:IMVT | Net Income | Immunovant, Inc.

Complete source-backed net income history.

Available history
2018-06-30 to 2026-06-30
Data captured

Historical Net Income

DateNet Income
2026-06-30-$153.22M
2026-03-31-$147.86M
2025-12-31-$110.64M
2025-09-30-$126.5M
2025-06-30-$120.61M
2025-03-31-$106.45M
2024-12-31-$111.12M
2024-09-30-$109.12M
2024-06-30-$87.15M
2024-03-31-$75.32M
2023-12-31-$51.42M
2023-09-30-$58.66M
2023-06-30-$73.94M
2023-03-31-$59.43M
2022-12-31-$63.23M
2022-09-30-$47.93M
2022-06-30-$40.37M
2022-03-31-$47.17M
2021-12-31-$41.39M
2021-09-30-$37.7M
2021-06-30-$30.47M
2021-03-31-$28.16M
2020-12-31-$31.78M
2020-09-30-$20.79M
2020-06-30-$26.71M
2020-03-31-$20.55M
2019-12-31-$11.3M
2019-09-30-$14.48M
2019-06-30-$20.06M
2019-03-31-$9.03M
2018-12-31-$8.85M
2018-09-30-$6.35M
2018-06-30-$4.37M

Annual Net Income

DateNet Income
2026-03-31-$505.61M
2025-03-31-$413.84M
2024-03-31-$259.34M
2023-03-31-$210.96M
2022-03-31-$156.73M
2021-03-31-$107.43M
2020-03-31-$66.39M
2019-03-31-$28.6M